SNPジェノタイピングと解析の世界市場レポート 2025年

SNPジェノタイピングと解析市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR20.6％で394億1,000万米ドルに成長します。予測期間中の成長は、集団ゲノミクス構想の拡大、希少疾患の診断重視の強化、コンパニオン診断とプレシジョン・オンコロジーの台頭、DTC（Direct-to-Consumer）ゲノミクスの需要拡大、ゲノム医療に対する規制当局の支援によって牽引されると予想されます。予測期間中に予想される主な動向には、ジェノタイピング技術の発展、人工知能とバイオインフォマティクスの統合、腫瘍学研究の発展、法医学および家系検査における利用の増加、携帯型ジェノタイピングデバイスの開発などがあります。

遺伝性疾患の有病率の上昇は、SNPジェノタイピングと解析市場の成長を促進すると予測されています。遺伝性疾患はDNAの異常によって引き起こされ、DNAの異常は片親または両親から遺伝するか、細胞分裂時の突然変異によって発生します。認知度が高まり、診断技術が向上するにつれて、より多くの遺伝性疾患が認識・診断されるようになり、遺伝性疾患の負担増加に寄与しています。SNPジェノタイピングと解析は、疾患リスク、進行、薬剤反応に関連する遺伝的変異を同定し、早期診断と個別化治療を可能にすることで、これらに重要な役割を果たしています。例えば、嚢胞性線維症オーストラリアが2024年2月に発表した報告書によると、オーストラリアにおける嚢胞性線維症患者数は、2021年の3,616人から2022年には3,738人に増加しました。その結果、遺伝性疾患の負担増がSNPジェノタイピングと解析市場の成長を促進すると予想されます。

SNPジェノタイピングと解析市場の主要企業は、農業分子育種用の大規模ローパス全ゲノムシーケンスなどの先進ソリューションの創出に注力しています。農業用全ゲノムシークエンシングでは、作物や家畜の完全な遺伝物質を解読し、収量、耐病性、環境適応性などの形質を改善します。例えば、2024年6月、中国のバイオテクノロジー企業であるMGI Tech社は、大規模な農業用ローパス全ゲノム配列決定のための効率的な全ワークフロー・ソリューションを発表しました。このソリューションは、農業二倍体種の分子育種ジェノタイピング用に設計されており、DNA抽出、ライブラリー調製、シーケンス、SNP &InDelコーリングを含みます。MGIのDNBSEQ-T7およびDNBSEQ-G400シーケンサーを使用し、超高スループットと柔軟性を提供するとともに、ブタ参照パネルおよびデータ解析ソフトウェアを使用することで、カスタムデータベースを作成することなくジェノタイピングを効率化します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界SNPジェノタイピングと解析PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のSNPジェノタイピングと解析市場：成長率分析
• 世界のSNPジェノタイピングと解析市場の実績：規模と成長, 2019-2024
• 世界のSNPジェノタイピングと解析市場の予測：規模と成長, 2024-2029, 2034F
• 世界SNPジェノタイピングと解析総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のSNPジェノタイピングと解析市場サンプルタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゲノムDNA
• リボ核酸（RNA）
• 遊離DNA（cfDNA）
• 血漿サンプル
• 全血
• 世界のSNPジェノタイピングと解析市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• マイクロアレイと遺伝子チップ
• Taqman対立遺伝子識別
• SNPピロシークエンス
• 応用生物科学SNPlex
• セクエモンマスアレイ Maldi-TOF
• その他のテクノロジー
• 世界のSNPジェノタイピングと解析市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病気の診断
• 薬理ゲノミクス
• 精密医療
• 法医学
• 農業と畜産
• 世界のSNPジェノタイピングと解析市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 調査室
• 製薬およびバイオテクノロジー企業
• 診断検査室
• 学術機関および政府機関
• 世界のSNPジェノタイピングと解析市場ゲノムDNAのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 全ゲノムシークエンシング（WGS）
• ターゲットシーケンシング
• マイクロアレイ
• 世界のSNPジェノタイピングと解析市場リボ核酸（RNA）の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• RNAシーケンス
• 発現プロファイリング
• マイクロアレイ
• 世界のSNPジェノタイピングと解析市場、遊離DNA（cfDNA）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 液体生検
• 非侵襲的出生前検査（NIPT）
• 腫瘍調査
• 世界のSNPジェノタイピングと解析市場血漿サンプルの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 循環腫瘍DNA（ctDNA）
• 液体生検の応用
• 診断
• 世界のSNPジェノタイピングと解析市場全血の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNA抽出と分析
• 血液ベースのゲノム研究
• 遺伝子型判定と分子診断

第7章 地域別・国別分析

• 世界のSNPジェノタイピングと解析市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のSNPジェノタイピングと解析市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• SNPジェノタイピングと解析市場：競合情勢
• SNPジェノタイピングと解析市場：企業プロファイル
  • Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Genomics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• PerkinElmer Inc.
• Beckman Coulter Life Sciences Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Natera Inc.
• Myriad Genetics Inc.
• Azenta Life Sciences Inc.
• LGC Limited
• Invitae Corporation
• Oxford Nanopore Technologies Limited
• Standard BioTools Inc.
• Pacific Biosciences of California Inc.
• NanoString Technologies Inc.
• Sophia Genetics SA
• Genedata AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• SNPジェノタイピングと解析市場2029：新たな機会を提供する国
• SNPジェノタイピングと解析市場2029：新たな機会を提供するセグメント
• SNPジェノタイピングと解析市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

SNP genotyping and analysis involves detecting and studying single nucleotide polymorphisms (SNPs) variations at a single base pair in the genome across different individuals or populations. This is done using techniques such as PCR, microarrays, or sequencing. The process allows researchers to explore genetic diversity, track inheritance patterns, and gain insights into individual variations in drug responses or susceptibility to certain conditions.

The main sample types used in SNP genotyping and analysis include genomic DNA, RNA, cell-free DNA (cfDNA), plasma, and whole blood. Genomic DNA refers to the complete set of genetic material in an organism, which holds all the instructions needed for its growth and functioning. Various technologies are used to conduct the analysis, including microarrays, gene chips, TaqMan allelic discrimination, SNP pyrosequencing, Applied Biosciences SNPlex, and Sequenom MassArray MALDI-TOF. These methods serve different applications such as disease diagnostics, pharmacogenomics, precision medicine, forensic science, and agriculture. The target users for these technologies include hospitals, research labs, pharmaceutical and biotech companies, diagnostic labs, as well as academic and government institutions.

The SNP genotyping and analysis market research report is one of a series of new reports from The Business Research Company that provides SNP genotyping and analysis market statistics, including SNP genotyping and analysis industry global market size, regional shares, competitors with an SNP genotyping and analysis market share, detailed SNP genotyping and analysis market segments, market trends and opportunities, and any further data you may need to thrive in the SNP genotyping and analysis industry. This SNP genotyping and analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The SNP genotyping and analysis market size has grown rapidly in recent years. It will grow from $15.45 billion in 2024 to $18.65 billion in 2025 at a compound annual growth rate (CAGR) of 20.7%. The growth observed during the historical period can be credited to factors such as increased funding for biomedical research, the expansion of personalized medicine efforts, the rise of agricultural genomics, the high prevalence of chronic diseases, and the emergence of commercial genomic services.

The SNP genotyping and analysis market size is expected to see rapid growth in the next few years. It will grow to $39.41 billion in 2029 at a compound annual growth rate (CAGR) of 20.6%. The growth during the forecast period is expected to be driven by the expansion of population genomics initiatives, a stronger emphasis on diagnosing rare diseases, the rise in companion diagnostics and precision oncology, growing demand for direct-to-consumer (DTC) genomics, and regulatory support for genomic medicine. Key trends anticipated for the forecast period include advancements in genotyping technologies, the integration of artificial intelligence and bioinformatics, growth in oncology research, increased use in forensic and ancestry testing, and the development of portable genotyping devices.

The rising prevalence of genetic diseases is anticipated to drive the growth of the SNP genotyping and analysis market. Genetic diseases are caused by abnormalities in DNA, which may either be inherited from one or both parents or occur due to mutations during cell division. As awareness grows and diagnostic technologies improve, more genetic disorders are being recognized and diagnosed, contributing to the increasing burden of genetic diseases. SNP genotyping and analysis play a crucial role in this by identifying genetic variations linked to disease risk, progression, and drug responses, enabling early diagnosis and personalized treatment. For example, according to a report published by Cystic Fibrosis Australia in February 2024, the number of people living with cystic fibrosis in Australia increased to 3,738 in 2022, up from 3,616 in 2021. As a result, the growing burden of genetic diseases is expected to fuel the growth of the SNP genotyping and analysis market.

Leading companies in the SNP genotyping and analysis market are focusing on creating advanced solutions, such as large-scale low-pass whole genome sequencing for agricultural molecular breeding. Agricultural whole genome sequencing involves decoding the complete genetic material of crops or livestock to improve traits such as yield, disease resistance, and environmental adaptability. For instance, in June 2024, MGI Tech, a biotechnology company based in China, introduced an efficient whole workflow solution for large-scale agricultural low-pass whole genome sequencing. This solution, designed for molecular breeding genotyping of agricultural diploid species, includes DNA extraction, library preparation, sequencing, and SNP & InDel calling. It utilizes MGI's DNBSEQ-T7 and DNBSEQ-G400 sequencers, offering ultra-high throughput and flexibility, alongside pig reference panels and data analysis software to streamline genotyping without the need for custom database creation.

In January 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies, acquired Verogen, Inc. The acquisition aims to enhance QIAGEN's leadership in human identification and forensics by integrating Verogen's advanced NGS tools and bioinformatics solutions into its existing portfolio. Verogen, a U.S.-based biotechnology company, specializes in SNP genotyping and analysis, offering tools such as the Forenseq Kintelligence kit and universal analysis software for forensic applications.

Major players in the snp genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International.

North America was the largest region in the SNP genotyping and analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in SNP genotyping and analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the SNP genotyping and analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The SNP genotyping and analysis market consists of revenues earned by entities by providing services such as DNA extraction and quality control, whole genome SNP analysis, SNP chip services, genetic association studies, and bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The SNP genotyping and analysis market also includes sales of genotyping platforms, genotyping assays/kits, bioinformatics software, Axiom genome-wide arrays, and bioinformatics analysis tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

SNP Genotyping And Analysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on snp genotyping and analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for snp genotyping and analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The snp genotyping and analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Sample Type: Genomic DNA; Ribonucleic Acid (RNA); Cell-Free DNA (cfDNA); Plasma Samples; Whole Blood
• 2) By Technology: Microarrays And GeneChips; Taqman Allelic Discrimination; SNP Pyrosequencing; Applied Biosciences SNPlex; Sequemon MassArray Maldi-TOF; Other Technologies
• 3) By Application: Disease Diagnostics; Pharmacogenomics; Precision Medicine; Forensic Science; Agriculture And Livestock
• 4) By End User: Hospitals And Clinics; Research Laboratories; Pharmaceutical And Biotechnological Companies; Diagnostic Laboratories; Academic And Government Institutions
• Subsegments:
• 1) By Genomic DNA: Whole Genome Sequencing (WGS); Targeted Sequencing; Microarrays
• 2) By Ribonucleic Acid (RNA): RNA-Seq; Expression Profiling; Microarrays
• 3) By Cell-Free DNA (cfDNA): Liquid Biopsy; Non-Invasive Prenatal Testing (NIPT); Oncology Research
• 4) By Plasma Samples: Circulating Tumor DNA (ctDNA); Liquid Biopsy Applications; Diagnostics
• 5) By Whole Blood: DNA Extraction And Analysis; Blood-Based Genomic Studies; Genotyping And Molecular Diagnostics
• Companies Mentioned: Roche Diagnostics GmbH; Thermo Fisher Scientific Inc.; Eurofins Genomics Inc.; Agilent Technologies Inc.; Illumina Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. SNP Genotyping And Analysis Market Characteristics

3. SNP Genotyping And Analysis Market Trends And Strategies

4. SNP Genotyping And Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global SNP Genotyping And Analysis Growth Analysis And Strategic Analysis Framework

• 5.1. Global SNP Genotyping And Analysis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global SNP Genotyping And Analysis Market Growth Rate Analysis
• 5.4. Global SNP Genotyping And Analysis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global SNP Genotyping And Analysis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global SNP Genotyping And Analysis Total Addressable Market (TAM)

6. SNP Genotyping And Analysis Market Segmentation

• 6.1. Global SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genomic DNA
• Ribonucleic Acid (RNA)
• Cell-Free DNA (cfDNA)
• Plasma Samples
• Whole Blood
• 6.2. Global SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microarrays And GeneChips
• Taqman Allelic Discrimination
• SNP Pyrosequencing
• Applied Biosciences SNPlex
• Sequemon MassArray Maldi-TOF
• Other Technologies
• 6.3. Global SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disease Diagnostics
• Pharmacogenomics
• Precision Medicine
• Forensic Science
• Agriculture And Livestock
• 6.4. Global SNP Genotyping And Analysis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Research Laboratories
• Pharmaceutical And Biotechnological Companies
• Diagnostic Laboratories
• Academic And Government Institutions
• 6.5. Global SNP Genotyping And Analysis Market, Sub-Segmentation Of Genomic DNA, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whole Genome Sequencing (WGS)
• Targeted Sequencing
• Microarrays
• 6.6. Global SNP Genotyping And Analysis Market, Sub-Segmentation Of Ribonucleic Acid (RNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• RNA-Seq
• Expression Profiling
• Microarrays
• 6.7. Global SNP Genotyping And Analysis Market, Sub-Segmentation Of Cell-Free DNA (cfDNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Biopsy
• Non-Invasive Prenatal Testing (NIPT)
• Oncology Research
• 6.8. Global SNP Genotyping And Analysis Market, Sub-Segmentation Of Plasma Samples, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Circulating Tumor DNA (ctDNA)
• Liquid Biopsy Applications
• Diagnostics
• 6.9. Global SNP Genotyping And Analysis Market, Sub-Segmentation Of Whole Blood, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Extraction And Analysis
• Blood-Based Genomic Studies
• Genotyping And Molecular Diagnostics

7. SNP Genotyping And Analysis Market Regional And Country Analysis

• 7.1. Global SNP Genotyping And Analysis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global SNP Genotyping And Analysis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific SNP Genotyping And Analysis Market

• 8.1. Asia-Pacific SNP Genotyping And Analysis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China SNP Genotyping And Analysis Market

• 9.1. China SNP Genotyping And Analysis Market Overview
• 9.2. China SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India SNP Genotyping And Analysis Market

• 10.1. India SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan SNP Genotyping And Analysis Market

• 11.1. Japan SNP Genotyping And Analysis Market Overview
• 11.2. Japan SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia SNP Genotyping And Analysis Market

• 12.1. Australia SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia SNP Genotyping And Analysis Market

• 13.1. Indonesia SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea SNP Genotyping And Analysis Market

• 14.1. South Korea SNP Genotyping And Analysis Market Overview
• 14.2. South Korea SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe SNP Genotyping And Analysis Market

• 15.1. Western Europe SNP Genotyping And Analysis Market Overview
• 15.2. Western Europe SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK SNP Genotyping And Analysis Market

• 16.1. UK SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany SNP Genotyping And Analysis Market

• 17.1. Germany SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France SNP Genotyping And Analysis Market

• 18.1. France SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy SNP Genotyping And Analysis Market

• 19.1. Italy SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain SNP Genotyping And Analysis Market

• 20.1. Spain SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe SNP Genotyping And Analysis Market

• 21.1. Eastern Europe SNP Genotyping And Analysis Market Overview
• 21.2. Eastern Europe SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia SNP Genotyping And Analysis Market

• 22.1. Russia SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America SNP Genotyping And Analysis Market

• 23.1. North America SNP Genotyping And Analysis Market Overview
• 23.2. North America SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA SNP Genotyping And Analysis Market

• 24.1. USA SNP Genotyping And Analysis Market Overview
• 24.2. USA SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada SNP Genotyping And Analysis Market

• 25.1. Canada SNP Genotyping And Analysis Market Overview
• 25.2. Canada SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America SNP Genotyping And Analysis Market

• 26.1. South America SNP Genotyping And Analysis Market Overview
• 26.2. South America SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil SNP Genotyping And Analysis Market

• 27.1. Brazil SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East SNP Genotyping And Analysis Market

• 28.1. Middle East SNP Genotyping And Analysis Market Overview
• 28.2. Middle East SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa SNP Genotyping And Analysis Market

• 29.1. Africa SNP Genotyping And Analysis Market Overview
• 29.2. Africa SNP Genotyping And Analysis Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa SNP Genotyping And Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa SNP Genotyping And Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. SNP Genotyping And Analysis Market Competitive Landscape And Company Profiles

• 30.1. SNP Genotyping And Analysis Market Competitive Landscape
• 30.2. SNP Genotyping And Analysis Market Company Profiles
  • 30.2.1. Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eurofins Genomics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. SNP Genotyping And Analysis Market Other Major And Innovative Companies

• 31.1. PerkinElmer Inc.
• 31.2. Beckman Coulter Life Sciences Inc.
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. QIAGEN N.V.
• 31.5. Natera Inc.
• 31.6. Myriad Genetics Inc.
• 31.7. Azenta Life Sciences Inc.
• 31.8. LGC Limited
• 31.9. Invitae Corporation
• 31.10. Oxford Nanopore Technologies Limited
• 31.11. Standard BioTools Inc.
• 31.12. Pacific Biosciences of California Inc.
• 31.13. NanoString Technologies Inc.
• 31.14. Sophia Genetics SA
• 31.15. Genedata AG

32. Global SNP Genotyping And Analysis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The SNP Genotyping And Analysis Market

34. Recent Developments In The SNP Genotyping And Analysis Market

35. SNP Genotyping And Analysis Market High Potential Countries, Segments and Strategies

• 35.1 SNP Genotyping And Analysis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 SNP Genotyping And Analysis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 SNP Genotyping And Analysis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer